메뉴 건너뛰기
The Lancet
Volumn 377, Issue 9773, 2011, Pages 1216-1218
A cytomegalovirus vaccine tames the troll of transplantation
Author keywords

[No Author keywords available]
Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS VACCINE; GANCICLOVIR; MIFAMURTIDE;
EID: 79953765463     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60435-2     Document Type: Note
Times cited : (2)
References (12)
  • 1
    • 0018449607 scopus 로고
    • Cytomegalovirus: The troll of transplantation
    • HH Balfour Jr. Cytomegalovirus: the troll of transplantation Arch Intern Med 139 1979 279 280
    • (1979) Arch Intern Med , vol.139 , pp. 279-280
    • Balfour Jr., H.H.1
  • 2
    • 20444453778 scopus 로고    scopus 로고
    • Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: A systematic review of randomised controlled trials
    • DOI 10.1016/S0140-6736(05)66553-1, PII S0140673605665531
    • EM Hodson, CA Jones, AC Webster Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials Lancet 365 2005 2105 2115 (Pubitemid 40826968)
    • (2005) Lancet , vol.365 , Issue.9477 , pp. 2105-2115
    • Hodson, E.M.1    Jones, C.A.2    Webster, A.C.3    Strippoli, G.F.M.4    Barclay, P.G.5    Kable, K.6    Vimalachandra, D.7    Craig, J.C.8
  • 3
    • 49449098166 scopus 로고    scopus 로고
    • Immunocompromised hosts: Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients
    • G Torres-Madriz, HW Boucher Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients Clin Infect Dis 47 2008 702 711
    • (2008) Clin Infect Dis , vol.47 , pp. 702-711
    • Torres-Madriz, G.1    Boucher, H.W.2
  • 4
    • 39749198242 scopus 로고    scopus 로고
    • Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: Late-onset disease and indirect consequences
    • DOI 10.1086/527397
    • C Legendre, M Pascual Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences Clin Infect Dis 46 2008 732 740 (Pubitemid 351321558)
    • (2008) Clinical Infectious Diseases , vol.46 , Issue.5 , pp. 732-740
    • Legendre, C.1    Pascual, M.2
  • 5
    • 79953743926 scopus 로고    scopus 로고
    • Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: A phase 2 randomised placebo-controlled trial
    • PD Griffiths, A Stanton, E McCarrell Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial Lancet 377 2011 1256 1263
    • (2011) Lancet , vol.377 , pp. 1256-1263
    • Griffiths, P.D.1    Stanton, A.2    McCarrell, E.3
  • 6
    • 0028820386 scopus 로고
    • Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
    • EA Walter, PD Greenberg, MJ Gilbert Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1995 1038 1044
    • (1995) N Engl J Med , vol.333 , pp. 1038-1044
    • Walter, E.A.1    Greenberg, P.D.2    Gilbert, M.J.3
  • 7
    • 0025854382 scopus 로고
    • Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant: A controlled trial
    • SA Plotkin, SE Starr, HM Friedman Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant: a controlled trial Ann Intern Med 114 1991 525 531
    • (1991) Ann Intern Med , vol.114 , pp. 525-531
    • Plotkin, S.A.1    Starr, S.E.2    Friedman, H.M.3
  • 8
    • 0028855321 scopus 로고
    • Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age
    • SP Adler, SE Starr, SA Plotkin Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age J Infect Dis 171 1995 26 32
    • (1995) J Infect Dis , vol.171 , pp. 26-32
    • Adler, S.P.1    Starr, S.E.2    Plotkin, S.A.3
  • 10
    • 36249015226 scopus 로고    scopus 로고
    • Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
    • EM Hodson, CA Jones, GF Strippoli Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients Cochrane Database Syst Rev 2 2007 CD005129
    • (2007) Cochrane Database Syst Rev , vol.2
    • Hodson, E.M.1    Jones, C.A.2    Strippoli, G.F.3
  • 11
    • 62749097289 scopus 로고    scopus 로고
    • Vaccine prevention of maternal cytomegalovirus infection
    • RF Pass, C Zhang, A Evans Vaccine prevention of maternal cytomegalovirus infection N Engl J Med 360 2009 1191 1199
    • (2009) N Engl J Med , vol.360 , pp. 1191-1199
    • Pass, R.F.1    Zhang, C.2    Evans, A.3
  • 12
    • 79951826211 scopus 로고    scopus 로고
    • Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection
    • C Wang, X Zhang, S Bialek, MJ Cannon Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection Clin Infect Dis 52 2011 e11 e13
    • (2011) Clin Infect Dis , vol.52
    • Wang, C.1    Zhang, X.2    Bialek, S.3    Cannon, M.J.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.